China – Chinese company approved for inhaled COVID-19 vaccine trial

China’s CanSino Biologics Inc (CanSinoBIO) said on Tuesday it won approval for a clinical trial in the country to develop a COVID-19 vaccine for inhalation.

The National Medical Products Administration approved the trial of the vaccine, jointly developed by CanSinoBIO and the Beijing Institute of Biotechnology, the company said.

The company’s COVID-19 vaccine for injection was recently approved for emergency use in Hungary…